This virtual medical affairs booth is provided by Sierra Oncology, Inc. (or the “Company”) for informational purposes only. Momelotinib is limited to investigational use only and has not been approved by any regulatory agency for commercial distribution.

Dr. Srdan Verstovsek, who is featured in the video recording regarding the MOMENTUM trial design, is a paid Principal Investigator engaged by Sierra Oncology, Inc. for its clinical trial. Statements contained in all presentations or recordings provided by the Company at this Congress are made as of the date of this presentation unless stated otherwise and are subject to change.

For additional information about Sierra Oncology, Inc., see https://www.sierraoncology.com/. The information provided at this virtual Congress does not constitute any medical advice. If you have any healthcare or medical questions, please consult with a medical professional. Any reproduction or distribution of this information, in whole or in part, or the disclosure of any of its contents, without the prior consent of the Company is prohibited.